Novartis seeks to deepen India innovation play
Swiss pharma major Novartis is sharpening its strategy in India as a pure-play innovator across core therapy segments, including cardiovascular, oncology, and immunology. The company is moving further up the value chain in India, with early scientific discovery and Phase I studies beginning to take shape.🕒 1 min read
Swiss pharma major Novartis is sharpening its strategy in India as a pure-play innovator across core therapy segments, including cardiovascular, oncology, and immunology. The company is moving further up the value chain in India, with early scientific discovery and Phase I studies beginning to take shape.
Continue Reading
- Morning Cycling Turns Fatal: Gurugram Man, 58, Hit By Speeding Car, Say Cops
- Airtel Q1 results: Net profit jumps 43% to Rs 5,948 crore as revenue, ARPU see strong growth
- Parliament Monsoon Session Day 16 Live Updates: Key Legislative Bills In Lok Sabha; Manipur Budget And GST Bills On Rajya Sabha Agenda
-
Opinion: Opinion | Trump’s Claims vs Numbers: Can India Really Replace 87 Million Tonnes Of Russian Oil?
-
Nashik TCS ‘Conversion’ Accused Nida Khan Claims She’s Pregnant, Wants Court Relief
- Bengaluru Man Beheads Wife After Fight, Carries Head To Police Station: Cops
- India Announces $680 Million Economic Package For Mauritius
-
“Biased”: Rahul Gandhi Slams Process To Select Next CBI Director
- Ajinkya Rahane Told Not To Bowl Varun Chakravarthy In Powerplay. Irfan Pathan Explains Why
-
Ex-Jharkhand Chief Minister Champai Soren Under House Arrest As Tribals’ Protest Against Land Acquisition
